CTX-8573

N/A

Report date: 2024/11/18 16:25:36

Base Information

Drug NameCTX-8573
Drug Alias NameCTX-8573
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-BCMALow affinity immunoglobulin gamma Fc region receptor III-A agonists
TargetsLow affinity immunoglobulin gamma Fc region receptor III-AB-cell maturation protein
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCompass Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesCompass Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A